Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects

Abstract

Alendronate is effective in the management of periodontitis associated bone loss. Gel based local delivery of the drug addresses the critical concern of exposing the patient to adverse effects of systemic administration.